Agency Forms Undergoing Paperwork Reduction Act Review, 71366-71367 [2023-22777]

Download as PDF 71366 Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–24–1359] ddrumheller on DSK120RN23PROD with NOTICES1 Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled ‘‘National Survey of Syringe Services Programs (NSSSP)’’, to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on May 4, 2023, to obtain comments from the public and affected agencies. CDC received no public comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570. Comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/ do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project The National Survey of Syringe Services Programs (NSSSP) (OMB Control No. 0920–1359, Exp. 12/31/ 2024)—Revision—National Center for HIV, Viral Hepatitis, STD, TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The primary purpose of the National Survey of Syringe Services Programs (NSSSP) is to strengthen and improve the ability of CDC and local and state partners to monitor and evaluate syringe services programs (SSPs) nationally, with the overall goal of supporting, sustaining, and improving SSPs nationwide and reducing infectious disease and other harms related to drug use. Findings from the 2020–2021 survey successfully characterized operational characteristics and services, funding resources, community relations, and key operational successes and challenges. The 2022 survey is currently being implemented. Revisions are being requested to address the increasing number of SSPs nationwide, the changing landscape of drug use nationally, additional SSP supplies and services provided, and ways in which SSPs are developing strategies to address the needs of people who use drugs (PWUD). The project will include all SSPs that are listed in a publicly available directory of all known SSPs in the United States maintained by the North American Syringe Exchange Network (NASEN; https://nasen.org). The project will also include SSPs in NASEN’s directory that do not wish to be publicly listed but have agreed to be contacted for research purposes, SSPs belonging to NASEN’s buyers’ club that are not part of the directory, respondents to prior RTI Arnold Ventures Surveys of SSPs that are not part of NASEN’s directory, and other SSPs proactively identified through searching state health department websites, funding agencies, state and regional networks, regional conferences, partner organization networks or webinars and via social media. SSPs will be sent a letter of invitation to participate in a 35-minute program survey. Participating programs will have the option of completing the survey via different modalities to enhance feasibility and comfort in completing the survey, for example via the Research Electronic Data Capture (REDCap) or a similarly secure webbased application. Other modalities for survey administration will include a coordinated telephone or videoconferencing interview. SSPs will be sent reminder letters for a six-month data collection period. SSPs that do not respond to prior reminders will be sent one final reminder, and if the SSP still does not want to participate, one (optional) question on why the SSP did not complete the survey will be offered. The survey will include questions on operational characteristics and services, funding resources, community relations, and key operational successes and challenges. Approximately 1000 SSPs will be able to participate in the survey. CDC anticipates that 20% of SSPs will decline to complete the survey, yielding 800 completed surveys per year. However, given that it is challenging to predict future response rates, we are requesting enough burden hours to allow 100% of SSPs to respond to the survey. CDC estimates that it will take 35 minutes to complete the survey, regardless of how the respondent chooses to complete it (i.e., selfadministered online or intervieweradministered by phone or videoconferencing). CDC estimates that it will take SSPs that do not respond to the initial survey invitation two minutes to respond to the additional question. CDC requests OMB approval for an estimated 616 annual burden hours. There are no other costs to respondents other than their time. Estimated Annualized Burden Hours Respondent Form Number of respondents Number of responses per respondent Average burden per response (in hours) All participating SSPs .................................... National Syringe Services Program Evaluation Survey. 1000 1 35/60 VerDate Sep<11>2014 17:03 Oct 13, 2023 Jkt 262001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\16OCN1.SGM 16OCN1 Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices Respondent Form Number of respondents Number of responses per respondent Average burden per response (in hours) Non-responding SSPs ................................... Non-Response Survey Item .......................... 1000 1 2/60 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2023–22777 Filed 10–13–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10241 and CMS– 10717] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments on the collection(s) of information must be received by the OMB desk officer by November 15, 2023. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent SUMMARY: VerDate Sep<11>2014 17:03 Oct 13, 2023 Jkt 262001 within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, please access the CMS PRA website by copying and pasting the following web address into your web browser: https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing. FOR FURTHER INFORMATION CONTACT: AGENCY: ddrumheller on DSK120RN23PROD with NOTICES1 71367 William Parham at (410) 786–4669. Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires federal agencies to publish a 30-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice that summarizes the following proposed collection(s) of information for public comment: 1. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: Survey of Retail Prices; Use: This information collection request provides for a survey of the average acquisition costs of all covered outpatient drugs purchased by retail community pharmacies. CMS may contract with a vendor to conduct monthly surveys of retail prices for covered outpatient drugs. Such prices represent a nationwide average of consumer purchase prices, net of discounts and rebates. The contractor SUPPLEMENTARY INFORMATION: PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 shall provide notification when a drug product becomes generally available and that the contract includes such terms and conditions as the Secretary shall specify, including a requirement that the vendor monitor the marketplace. CMS has developed a National Average Drug Acquisition Cost (NADAC) for states to consider when developing reimbursement methodology. The NADAC is a pricing benchmark that is based on the national average costs that pharmacies pay to acquire Medicaid covered outpatient drugs. This pricing benchmark is based on drug acquisition costs collected directly from pharmacies through a nationwide survey process. This survey is conducted on a monthly basis to ensure that the NADAC reference file remains current and up-to-date. Form Number: CMS–10241 (OMB control number 0938–1041); Frequency: Monthly; Affected Public: Private sector (Business or other for-profits); Number of Respondents: 72,000; Total Annual Responses: 72,000; Total Annual Hours: 36,000. (For policy questions regarding this collection contact: Robert Giles at 667–290–8626.) 2. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Medicare Part C and Part D Program Audit and IndustryWide Part C Timeliness Monitoring Project (TMP) Protocols; Use: Under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and implementing regulations at 42 CFR parts 422 and 423, Medicare Part D plan sponsors and Medicare Advantage organizations are required to comply with all Medicare Parts C and D program requirements. CMS’ annual audit plan ensures that we evaluate sponsoring organizations’ compliance with these requirements by conducting program audits that focus on high-risk areas that have the greatest potential for beneficiary harm. As such, CMS has developed the following audit protocols for use by sponsoring organizations to prepare for their audit: • Compliance Program Effectiveness (CPE) • Part D Formulary and Benefit Administration (FA) • Part D Coverage Determinations, Appeals, and Grievances (CDAG) E:\FR\FM\16OCN1.SGM 16OCN1

Agencies

[Federal Register Volume 88, Number 198 (Monday, October 16, 2023)]
[Notices]
[Pages 71366-71367]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22777]



[[Page 71366]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-24-1359]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``National Survey of Syringe Services 
Programs (NSSSP)'', to the Office of Management and Budget (OMB) for 
review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
May 4, 2023, to obtain comments from the public and affected agencies. 
CDC received no public comments related to the previous notice. This 
notice serves to allow an additional 30 days for public and affected 
agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    The National Survey of Syringe Services Programs (NSSSP) (OMB 
Control No. 0920-1359, Exp. 12/31/2024)--Revision--National Center for 
HIV, Viral Hepatitis, STD, TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The primary purpose of the National Survey of Syringe Services 
Programs (NSSSP) is to strengthen and improve the ability of CDC and 
local and state partners to monitor and evaluate syringe services 
programs (SSPs) nationally, with the overall goal of supporting, 
sustaining, and improving SSPs nationwide and reducing infectious 
disease and other harms related to drug use. Findings from the 2020-
2021 survey successfully characterized operational characteristics and 
services, funding resources, community relations, and key operational 
successes and challenges. The 2022 survey is currently being 
implemented. Revisions are being requested to address the increasing 
number of SSPs nationwide, the changing landscape of drug use 
nationally, additional SSP supplies and services provided, and ways in 
which SSPs are developing strategies to address the needs of people who 
use drugs (PWUD).
    The project will include all SSPs that are listed in a publicly 
available directory of all known SSPs in the United States maintained 
by the North American Syringe Exchange Network (NASEN; https://nasen.org). The project will also include SSPs in NASEN's directory 
that do not wish to be publicly listed but have agreed to be contacted 
for research purposes, SSPs belonging to NASEN's buyers' club that are 
not part of the directory, respondents to prior RTI Arnold Ventures 
Surveys of SSPs that are not part of NASEN's directory, and other SSPs 
proactively identified through searching state health department 
websites, funding agencies, state and regional networks, regional 
conferences, partner organization networks or webinars and via social 
media. SSPs will be sent a letter of invitation to participate in a 35-
minute program survey. Participating programs will have the option of 
completing the survey via different modalities to enhance feasibility 
and comfort in completing the survey, for example via the Research 
Electronic Data Capture (REDCap) or a similarly secure web-based 
application. Other modalities for survey administration will include a 
coordinated telephone or videoconferencing interview. SSPs will be sent 
reminder letters for a six-month data collection period. SSPs that do 
not respond to prior reminders will be sent one final reminder, and if 
the SSP still does not want to participate, one (optional) question on 
why the SSP did not complete the survey will be offered.
    The survey will include questions on operational characteristics 
and services, funding resources, community relations, and key 
operational successes and challenges. Approximately 1000 SSPs will be 
able to participate in the survey. CDC anticipates that 20% of SSPs 
will decline to complete the survey, yielding 800 completed surveys per 
year. However, given that it is challenging to predict future response 
rates, we are requesting enough burden hours to allow 100% of SSPs to 
respond to the survey. CDC estimates that it will take 35 minutes to 
complete the survey, regardless of how the respondent chooses to 
complete it (i.e., self-administered online or interviewer-administered 
by phone or videoconferencing). CDC estimates that it will take SSPs 
that do not respond to the initial survey invitation two minutes to 
respond to the additional question.
    CDC requests OMB approval for an estimated 616 annual burden hours. 
There are no other costs to respondents other than their time.

Estimated Annualized Burden Hours

----------------------------------------------------------------------------------------------------------------
                                                                                   Number of      Average burden
             Respondent                        Form              Number of       responses per     per response
                                                                respondents       respondent        (in hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs..............  National Syringe                  1000                 1            35/60
                                       Services Program
                                       Evaluation Survey.

[[Page 71367]]

 
Non-responding SSPs.................  Non-Response Survey               1000                 1             2/60
                                       Item.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2023-22777 Filed 10-13-23; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.